Erythrocyte membrane fluidity: A novel biomarker of residual cardiovascular risk in type 2 diabetes.
Bianchetti G, Cefalo CMA, Ferreri C, Sansone A, Vitale M, Serantoni C, Abeltino A, Mezza T, Ferraro PM, De Spirito M, Riccardi G, Giaccari A, Maulucci G.
Bianchetti G, et al. Among authors: serantoni c.
Eur J Clin Invest. 2024 Mar;54(3):e14121. doi: 10.1111/eci.14121. Epub 2023 Nov 6.
Eur J Clin Invest. 2024.
PMID: 37929812